Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin.

Literature DB >> 3134211

Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin.

Abstract

A total of 585 Mycobacterium tuberculosis strains isolated during a three-year period in Sweden were tested for in vitro susceptibility to amikacin in comparison with streptomycin. Resistance to streptomycin was seen in 27 of the isolates (4.6%). These isolates had been obtained from 22 patients, a majority of which were non-European immigrants. All but one of the streptomycin-resistant isolates were susceptible to amikacin. None of 263 streptomycin-susceptible isolates tested was resistant to amikacin. Amikacin appears to be an alternative to streptomycin in the treatment of patients with streptomycin-resistant Mycobacterium tuberculosis.

Entities: Chemical Species

Mesh：

Substances：
Amikacin
Streptomycin

Year: 1988 PMID： 3134211 DOI： 10.1007/bf01963078

Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN： 0934-9723 Impact factor: 3.267

9 in total

1. Activity of amikacin against Mycobacterium tuberculosis.

Authors: J A Garcia Rodriguez; F Martin Luengo; M C Saenz Gonzalez
Journal: J Antimicrob Chemother Date: 1978-05 Impact factor: 5.790

2. Amikacin in experimental tuberculosis of guinea pigs.

Authors: T Fodor
Journal: Acta Microbiol Acad Sci Hung Date: 1982

3. National survey of tuberculosis notifications in England and Wales in 1983: characteristics of disease. Report from the Medical Research Council Tuberculosis and Chest Diseases Unit.

Authors:
Journal: Tubercle Date: 1987-03

4. Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media.

Authors: G Middlebrook; Z Reggiardo; W D Tigertt
Journal: Am Rev Respir Dis Date: 1977-06

5. In vitro anti-mycobacterial activity of some new amino-glycoside antibiotics.

Authors: P R Gangadharam; E R Candler
Journal: Tubercle Date: 1977-03

6. MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors: G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal: Bull World Health Organ Date: 1963 Impact factor: 9.408

7. Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.

Authors: W E Sanders; C Hartwig; N Schneider; R Cacciatore; H Valdez
Journal: Tubercle Date: 1982-09

8. Rapid drug-susceptibility testing of Mycobacterium tuberculosis.

Authors: D E Snider; R C Good; J O Kilburn; L F Laskowski; R H Lusk; J J Marr; Z Reggiardo; G Middlebrook
Journal: Am Rev Respir Dis Date: 1981-04

Review 9. An overview of amikacin.

Authors: A M Ristuccia; B A Cunha
Journal: Ther Drug Monit Date: 1985 Impact factor: 3.681

9 in total

6 in total

Susceptibility of streptomycin-resistant Mycobacterium tuberculosis strains to amikacin.

1. Activity of amikacin against Mycobacterium tuberculosis.

2. Amikacin in experimental tuberculosis of guinea pigs.

3. National survey of tuberculosis notifications in England and Wales in 1983: characteristics of disease. Report from the Medical Research Council Tuberculosis and Chest Diseases Unit.

4. Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media.

5. In vitro anti-mycobacterial activity of some new amino-glycoside antibiotics.

6. MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

7. Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.

8. Rapid drug-susceptibility testing of Mycobacterium tuberculosis.

Review 9. An overview of amikacin.

Review 1. Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Review 2. Aminoglycoside therapy. Current use and future prospects.

3. Spread of drug-resistant pulmonary tuberculosis in Estonia.

4. Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau.

5. Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.

6. Biochemical heterogeneity of Mycobacterium tuberculosis complex isolates in Guinea-Bissau.